| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | 0.071 | 0.04 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.082 | 0.04 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.1 | 0.04 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.04 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.072 | 0.04 |
| mRNA | HG-6-64-1 | GDSC1000 | pan-cancer | AAC | 0.069 | 0.04 |
| mRNA | AT-7519 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.04 |
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | -0.07 | 0.04 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.12 | 0.05 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | 0.058 | 0.05 |